Tudor Investment Corp’s Audentes Therapeutics, Inc BOLD Stock Holding History

Tudor Investment Corp’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-451,689	Closed	-$27M	–	1480
2019 Q4	$27M	Buy	+451,689	New	+$17M	1.21%	6
2019 Q3	–	Sell	-8,064	Closed	-$305K	–	1454
2019 Q2	$305K	Buy	+8,064	New	+$310K	0.01%	854
2018 Q3	–	Sell	-14,917	Closed	-$570K	–	1346
2018 Q2	$570K	Sell	14,917 -3,407	-19%	-$126K	0.02%	628
2018 Q1	$551K	Buy	+18,324	New	+$620K	0.02%	531

Tudor Investment Corp's BOLD Position: Q1 2020 in Review

Tudor Investment Corp sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 451,689 shares — an estimated $27M sold.

Tudor Investment Corp first reported a position in BOLD in Q1 2018 and held it in 4 quarters. The position peaked at $27M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Tudor Investment Corp reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Tudor Investment Corp sold 451,689 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $27M.
Tudor Investment Corp first reported a position in Audentes Therapeutics, Inc in Q1 2018 and held it in 4 quarters.
Tudor Investment Corp's Audentes Therapeutics, Inc position peaked at $27M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Tudor Investment Corp's 13F filing for Q1 2020, filed 15 May 2020.